6,500
UK employees including 4,300 at these sites
Edinburgh
Macclesfield
1,800 employees
AstraZeneca’s second-largest
manufacturing site and its
European centre for packing
Birmingham
Cambridge
2,500
HQ and multiple sites.
1,600 scientists will be
working at its new R&D
facility
London
The Anglo-Swedish group is preparing for parallel testing of drugs at its Swedish site in Gothenburg.
The company behind the cholesterol pill Crestor and cutting-edge cancer treatments is spending up to £50m on measures including revising transport routes and boosting stockpiles of medicines. It is lifting inventories from three months’ supply to four in warehouses in the EU, and to four and a half months in the UK.
6,500
UK employees including 4,300 at these sites
The Anglo-Swedish group is preparing for parallel testing of drugs at its Swedish site in Gothenburg.
The company behind the cholesterol pill Crestor and cutting-edge cancer treatments is spending up to £50m on measures including revising transport routes and boosting stockpiles of medicines. It is lifting inventories from three months’ supply to four in warehouses in the EU, and to four and a half months in the UK.
Edinburgh
Macclesfield
1,800 employees
AstraZeneca’s second-largest
manufacturing site and its
European centre for packing
Birmingham
Cambridge
2,500
HQ and multiple sites.
1,600 scientists will be
working at its new R&D
facility
London